by Jackie (née Heneghan) Peck | Mar 5, 2014 | Blog, Community Pharmacy, Pharmacy Brands, Pharmacy Suppliers
It is quite a common occurrence to receive a call from a new client enquiring about how to obtain a Wholesale Dealer’s License or WDL. First of all, I advise politely that the terminology has now changed to a Wholesale Distribution Authorisation or WDA(H) but...
by Jackie (née Heneghan) Peck | Mar 4, 2014 | Behind the scenes, Blog, Community Pharmacy, Pharmacy Brands, Pharmacy Suppliers, Regulation
Do you want to have one? Is it worth the cost and effort? If you would like more information please contact [email protected] for an informal discussion. Or you may want to find out more about GDP and the Roles and Responsibilities of a” MHRA RP “? The...
by Jackie (née Heneghan) Peck | Mar 4, 2014 | Behind the scenes, Blog, Community Pharmacy, Pharmacy Brands, Pharmacy Suppliers, Regulation
Are your surgeries applying for CQC registration? Do they need help with the application or SOPs or to prepare for their inspections? Do they need help with their staff training? If you want to get involved and are not sure what is involved, talk to Pharmacy...
by Jackie (née Heneghan) Peck | Feb 14, 2014 | Behind the scenes, Blog, Community Pharmacy, Pharmacy Brands, Pharmacy Suppliers
This week we were out visiting some clients and one pharmacist told us: “You will be glad to know that in my position as a pharmacy advisor, I have taken on board all you said about cold chain storage and I have ordered new fridges for my client! I have also bought a...
by Jackie (née Heneghan) Peck | Feb 14, 2014 | Behind the scenes, Blog, Pharmacy Suppliers
As RPs, we have always been aware of the importance of using our training, visits and audits to effect positive changes in the practices of our wholesalers. It is important to make people feel as comfortable as possible during our visits so that they speak openly. We...
by Jackie (née Heneghan) Peck | Feb 12, 2014 | Behind the scenes, Blog, Pharmacy Brands, Pharmacy Suppliers, Regulation
Following the aftermath of the PIP scandal where industrial silicone was found to have been, fraudulently, used in the manufacture of breast implants, combined with some other high profile device failures, the European Commission, on the 26th September 2012, released...